Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Adds Eight Vaccines To Bring To 15 Number In National Campaign

This article was originally published in PharmAsia News

Executive Summary

China is adding another eight vaccines to its national immunization drive, now covering free shots against 15 infectious diseases. Considered the world's largest vaccination effort, the Chinese effort's newly added vaccines include four formulated for children. The rest of the 14 vaccines to be used are aimed at people considered especially susceptible to certain epidemics. The newly added vaccines are intended to protect against hepatitis A and an epidemic of cerebrospinal meningitis. The plan is to have more than 90 percent of the nation's children vaccinated within two years. (Click here for more

China is adding another eight vaccines to its national immunization drive, now covering free shots against 15 infectious diseases. Considered the world's largest vaccination effort, the Chinese effort's newly added vaccines include four formulated for children. The rest of the 14 vaccines to be used are aimed at people considered especially susceptible to certain epidemics. The newly added vaccines are intended to protect against hepatitis A and an epidemic of cerebrospinal meningitis. The plan is to have more than 90 percent of the nation's children vaccinated within two years. (Click here for more )

"Vaccination Drive Boosted To 15 Diseases" - Xinhua (China) (2/19/08

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067705

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel